Measles immunisation in developing countries

BMJ 1994; 308 doi: https://doi.org/10.1136/bmj.308.6925.411b (Published 05 February 1994) Cite this as: BMJ 1994;308:411
  1. S K Obaro
  1. Department of Immunology, Chelsea and Westminister Hospital London SW10 9NH.

    EDITOR, - Peter Aaby and colleagues raise issues about measles immunisation in developing countries that deserve comment and further evaluation.1 Measles before the age of 9 months remains an important problem in developing countries that was understated in the paper. In densely populated urban areas of west Africa the incidence may be as high as 30%.2 In a recent unpublished study of measles antibody levels in some 350 infants in Zaria, northern Nigeria, serological susceptibility …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription